Rapid identification and antimicrobial susceptibility testing of gram-negative bacilli from blood cultures by the AutoMicrobic system.

Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates. J Clin Microbiol (1989) 5.26

Clinical laboratory comparison of the 10-ml isolator blood culture system with BACTEC radiometric blood culture media. J Clin Microbiol (1984) 2.64

Rapid antimicrobial susceptibility testing of Gram-negative clinical isolates with the AutoMicrobic system. J Clin Microbiol (1984) 1.84

Rapid automated identification of gram-negative bacilli from blood cultures with the AutoMicrobic system. J Clin Microbiol (1982) 1.61

Identification and susceptibility testing of Enterobacteriaceae and Pseudomonas aeruginosa by direct inoculation from positive BACTEC blood culture bottles into Vitek 2. J Clin Microbiol (2004) 1.38

Direct susceptibility testing with positive BacT/Alert blood cultures by using MicroScan overnight and rapid panels. J Clin Microbiol (1998) 1.31

Use of positive blood cultures for direct identification and susceptibility testing with the vitek 2 system. J Clin Microbiol (2004) 1.25

Manual and automated instrumentation for identification of Enterobacteriaceae and other aerobic gram-negative bacilli. Clin Microbiol Rev (2005) 1.20

Evaluation of rapid identification of gram-positive cocci in positive blood cultures by use of the AutoMicrobic system Gram-Positive Identification Card. J Clin Microbiol (1984) 1.19

Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures. J Clin Microbiol (2000) 1.12

Comparison of four rapid methods for identification of Enterobacteriaceae from blood cultures. J Clin Microbiol (1983) 1.03

Direct identification and susceptibility testing of gram-negative bacilli from BACTEC bottles by use of the MS-2 system with updated bacterial identification software. J Clin Microbiol (1984) 1.02

Rapid intrinsic fluorescence method for direct identification of pathogens in blood cultures. MBio (2013) 0.88

Rapid identification and antimicrobial susceptibility profiling of Gram-positive cocci in blood cultures with the Vitek 2 system. Eur J Clin Microbiol Infect Dis (2009) 0.84

Evaluation of the Cobas-Bact system for direct and rapid identification and antimicrobial susceptibility testing of gram-negative rods from positive blood culture broths. J Clin Microbiol (1989) 0.81

Direct antimicrobial susceptibility testing of gram-negative bacilli in blood cultures by an electrochemical method. J Clin Microbiol (1998) 0.80

Evaluation of Verigene Blood Culture Test Systems for Rapid Identification of Positive Blood Cultures. Biomed Res Int (2016) 0.75

Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study. Antimicrob Agents Chemother (1975) 17.12

Automated microbiological detection/identification system. J Clin Microbiol (1977) 16.88

Multi-laboratory evaluation of an automated microbial detection/identification system. J Clin Microbiol (1978) 5.74

Presumptive identification of bacteria from blood cultures in four hours. J Infect Dis (1971) 4.70

Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med (1980) 4.45

Collaborative investigation of the AutoMicrobic System Enterobacteriaceae biochemical card. J Clin Microbiol (1980) 4.28

Rapid automated disgnosis of bacteremia by impedance detection. J Clin Microbiol (1977) 3.54

A review of positive blood cultures: identification and source of microorganisms and patterns of sensitivity to antibiotics. Rev Infect Dis (1980) 3.37

Laboratory experience with a radiometric method for detecting bacteremia. J Clin Microbiol (1975) 3.02

Standardization of direct susceptibility test for blood cultures. J Clin Microbiol (1979) 2.69

Comparison of direct and standardized antimicrobial susceptibility testing of positive blood cultures. Antimicrob Agents Chemother (1976) 2.30

Direct inoculation procedure for the rapid classification of bacteria from blood culture. J Clin Microbiol (1975) 2.09

Inoculation of API-20E from positive blood cultures. J Clin Microbiol (1976) 1.67

Comparison of direct and standard antimicrobial disk susceptibility testing for bacteria isolated from blood. J Clin Microbiol (1979) 1.54

Rapid identification of Enterobacteriaceae from blood cultures with the Micro-ID system. J Clin Microbiol (1979) 1.47

Modified inoculum for the enteric Minitek system from positive blood cultures. J Clin Microbiol (1979) 0.99

Counterimmunoelectrophoresis for rapid identification of blood-culture isolates. Am J Clin Pathol (1979) 0.93

Automated detection of microbial growth in blood cultures by using stainless-steel electrodes. J Clin Microbiol (1980) 0.88

Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (2000) 15.16

In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother (1972) 11.05

Evaluation of accuracy of multitest micromethod system for identification of Enterobacteriaceae. Appl Microbiol (1971) 10.28

Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med (1988) 9.10

Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by amplification of rRNA. J Clin Microbiol (1993) 6.38

Clinical utility of thoracoscopy. Chest (1992) 6.34

Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility. Am J Clin Pathol (1970) 5.61

Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA (2001) 5.54

Practical method for isolation of anerobic bacteria in the clinical laboratory. Appl Microbiol (1971) 5.45

Identification of members of the family Enterobacteriaceae by the R-B system. Appl Microbiol (1970) 5.27

Comparison of three blood culture media for recovery of anaerobic bacteria. Appl Microbiol (1973) 5.22

Anaerobic bacteremia. Mayo Clin Proc (1972) 4.79

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial. J Clin Oncol (2001) 4.73

Microwave oven for melting laboratory media. J Clin Microbiol (1978) 4.33

Collaborative investigation of the AutoMicrobic System Enterobacteriaceae biochemical card. J Clin Microbiol (1980) 4.28

Evaluation of reagent-impregnated strips for identification of Enterobacteriaceae. Am J Med Technol (1971) 3.60

Isolation and indentification of anaerobic bacteria in the clinical laboratory. A 2-year experience. Mayo Clin Proc (1974) 3.54

Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis (1988) 3.52

Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16

Klebsiella in faecal flora of renal-transplant patients. Lancet (1970) 3.14

Evaluation of the enterotube system for identification of members of the family Enterobacteriaceae. Appl Microbiol (1971) 3.11

Evaluation of enrichment, storage, and age of blood agar medium in relation to its ability to support growth of anaerobic bacteria. J Clin Microbiol (1976) 3.09

Linkage between the poly-L-lysine gene and the locus controlling the major histocompatibility antigens in strain 2 guinea pigs. Proc Natl Acad Sci U S A (1970) 2.89

Biochemical and clinical characteristics and antibiotic susceptibility of atypical Enterobacter cloacae. Appl Microbiol (1969) 2.87

Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis (1989) 2.86

Evaluation of the Auxotab Enteric 1 System for identification of Enterobacteriaceae. Appl Microbiol (1972) 2.85

In vitro studies of piperacilin, a new semisynthetic penicillin. Antimicrob Agents Chemother (1978) 2.82

Clinical isolation of Yersinia enterocolitica: cold temperature enrichment. J Clin Microbiol (1975) 2.76

Genetic control of immune responsiveness to a glutamic acid, alanine, tyrosine copolymer in mice. I. Linkage of responsiveness to H-2 genotype. J Immunol (1971) 2.60

API and Minitek systems in identification of clinical isolates of anaerobic gram-negative bacilli and Clostridium species. J Clin Microbiol (1979) 2.54

Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med (1983) 2.53

Epidemiologic significance of Klebsiella pneumoniae. A 3-month study. Mayo Clin Proc (1971) 2.51

Prevalence of serotypes of Salmonella. Appl Microbiol (1969) 2.50

Clinical and bacteriologic studies of anaerobic gram-positive cocci. Mayo Clin Proc (1972) 2.48

Diverticula of the Small Bowel. Ann Surg (1934) 2.44

Heamophilus vaginalis (Corynebacterium vaginal): method for isolation and rapid biochemical identification. Health Lab Sci (1977) 2.37

Bacteroides bacteremia. Minn Med (1970) 2.36

Bacterial (suppurative) arthritis in the adult. J Bone Joint Surg Am (1970) 2.26

Evaluation of the MS-2 system for rapid identification of Enterobacteriaceae. J Clin Microbiol (1980) 2.26

Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.23

Comparison of human fibroblast cells and primary rabbit kidney cells for isolation of herpes simplex virus. J Clin Microbiol (1984) 2.22

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med (1985) 2.12

Clinical evaluation of a lysis-centrifugation technique for the detection of septicemia. JAMA (1983) 2.12

Analysis of DNA sequences in forty-year-old paraffin-embedded thin-tissue sections: a bridge between molecular biology and classical histology. Cancer Res (1988) 2.06

Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens by a monoclonal antibody method. J Clin Microbiol (1986) 2.05

Comparison of rates of virus isolation from leukocyte populations separated from blood by conventional and Ficoll-Paque/Macrodex methods. J Clin Microbiol (1979) 2.04

Office-based test systems for HIV antibody. N Engl J Med (1993) 2.02

Hemagglutinin-specific cytotoxic T-cell response during influenza infection. J Exp Med (1977) 1.97

Clinical evaluation of the AutoMicrobic system Yeast Biochemical Card for rapid identification of medically important yeasts. J Clin Microbiol (1981) 1.94

Histocompatibility type and immune responsiveness in random bred Hartley strain guinea pigs. J Exp Med (1970) 1.90

Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations. Ann Intern Med (1977) 1.90

Brain abscess with Corynebacterium hemolyticum: report of a case. Am J Clin Pathol (1971) 1.87

Non-radioactive single strand conformation polymorphism (SSCP) using the Pharmacia 'PhastSystem'. Nucleic Acids Res (1991) 1.86

Nosocomially acquired bacteriuria due to Proteus rettgeri and Providencia stuartii. Am J Clin Pathol (1973) 1.83

Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significance. JAMA (1970) 1.80

In vitro susceptibility of gram-negative bacilli to gentamicin. Mayo Clin Proc (1970) 1.72

Cell-adhesive motif in region II of malarial circumsporozoite protein. Science (1990) 1.69

An analgesia circuit activated by cannabinoids. Nature (1998) 1.68

Anti-Salmonella agglutinins in chronic active liver disease. Lancet (1971) 1.67

Expression of yeast apurinic/apyrimidinic endonuclease (APN1) protects lung epithelial cells from bleomycin toxicity. Am J Respir Cell Mol Biol (2001) 1.63

The neurogenetics of mucolipidosis type IV. Neurology (2002) 1.62

Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease. Blood Cells Mol Dis (2000) 1.61

In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin. Antimicrob Agents Chemother (1977) 1.60

Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke (2001) 1.56

Enhanced immunogenicity of chemically-coated syngeneic tumor cells. Proc Natl Acad Sci U S A (1971) 1.55

120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest (1992) 1.53

Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens. Proc Natl Acad Sci U S A (1977) 1.53

In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration. Mayo Clin Proc (1970) 1.53

Clinical and bacteriologic observations on the proposed species, Enterobacter agglomerans (the Herbicola-Lathyri bacteria). Mayo Clin Proc (1972) 1.52

Effects of medium and inoculum on antimicrobial susceptibility of anaerobic bacteria. Am J Clin Pathol (1974) 1.52

Site of action of antilymphocyte globulin. Lancet (1967) 1.51

Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide-dependent pathway. An in vitro model of neutrophil-mediated lung injury. Am Rev Respir Dis (1984) 1.50

Enumeration and speciation of enterococci found in marine and intertidal sediments and coastal water in southern California. J Appl Microbiol (2005) 1.50

Infections caused by Klebsiella ozaenae: a changing disease spectrum. J Clin Microbiol (1978) 1.50

Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens. Antimicrob Agents Chemother (1981) 1.49

Detection of human papillomavirus in normal and dysplastic tissue by the polymerase chain reaction. Lab Invest (1988) 1.48

Interaction of vitronectin with Pneumocystis carinii: evidence for binding via the heparin binding domain. J Lab Clin Med (1995) 1.48

Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46

Oxidant injury of lung parenchymal cells. J Clin Invest (1981) 1.44

Recent Trends of Some Infectious Diseases. Br Med J (1942) 1.44

Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med (1980) 1.44

Simplified method of anaerobic incubation. Appl Microbiol (1971) 1.44

Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations. Neurology (2001) 1.42

Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum (1988) 1.41

Functional impairment of bronchoalveolar lavage phospholipids in early Pneumocystis carinii pneumonia in rats. J Lab Clin Med (1996) 1.41

Comparison of the Minitek test system with a conventional screening procedure for identification of Enterobacteriaceae. Health Lab Sci (1978) 1.40

Detection of human papillomavirus in formalin-fixed, invasive squamous carcinomas using the polymerase chain reaction. Am J Surg Pathol (1989) 1.40

Isolation of Plasmodium berghei (malaria) parasites by ammonium chloride lysis of infected erythrocytes. Nat New Biol (1971) 1.38

Comparison of total coliform, fecal coliform, and enterococcus bacterial indicator response for ocean recreational water quality testing. Water Res (2003) 1.38

Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells. J Clin Invest (1990) 1.37

Rapid characterization of salmonella organisms by means of pyrolysis-gas-liquid chromatography. Anal Chem (1972) 1.35

Rapid herpes simplex virus detection in clinical samples submitted to a state virology laboratory. J Clin Microbiol (1985) 1.35

Pneumocystis carinii: inhibition of lung cell growth mediated by parasite attachment. J Clin Invest (1990) 1.33

In vitro antibacterial activity of minocycline and effect of agar medium utilized in its susceptibility testing. Appl Microbiol (1970) 1.30

Yersinia enterocolitica: in vitro antimicrobial susceptibility. Antimicrob Agents Chemother (1978) 1.30

Fungal endophthalmitis following intraocular lens implantation. A surgical epidemic. Arch Ophthalmol (1980) 1.30

Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein. J Clin Invest (1991) 1.29

Comparison of media for isolation of salmonellae and shigellae from fecal specimens. Appl Microbiol (1971) 1.29